Related Experiment Videos

Pulmonary fat accumulation after intralipid infusion in the preterm infant

Lancet (London, England)
|October 18, 1980
PubMed

Insights

Fat accumulation in the lungs was observed in preterm infants following Intralipid infusion. This finding, even at recommended rates, suggests a potential risk of lung complications in vulnerable neonates.

Area of Science:

  • Neonatalogy
  • Pediatric Pathology
  • Clinical Pharmacy

Background:

  • Intralipid (parenteral fat emulsion) is commonly used for nutritional support in preterm infants.
  • Potential adverse effects of Intralipid, particularly on pulmonary function, require thorough investigation.

Purpose of the Study:

  • To investigate the presence and characteristics of lung fat accumulation in preterm infants following Intralipid infusion.
  • To determine if Intralipid infusion, even at recommended rates, is associated with pulmonary lipid deposition.

Main Methods:

  • Histological examination of lung tissue from preterm infants who died after Intralipid infusion.
  • Analysis of lung homogenates for linoleic acid concentration as a marker for Intralipid.
  • Comparison with infants who did not receive parenteral fat emulsion.

Main Results:

  • Pulmonary fat accumulation, characterized by engorged capillaries with lipid globules, was found in all eight infants studied.
  • Linoleic acid concentration was significantly higher in infants receiving Intralipid (p < 0.001).
  • Fat accumulation occurred even when infusion rates were below recommended maximums and plasma was not visibly lipemic.

Conclusions:

  • Intralipid infusion can lead to significant, potentially unrecognised, fat accumulation in the lungs of preterm infants.
  • This pulmonary lipid deposition may exacerbate ventilation/perfusion inequalities, impacting respiratory function.
  • Careful monitoring and consideration of infusion protocols may be warranted.

Related Concept Videos